To investigate whether KMT2D affects NSCLC malignant capacities via modulation of macrophage polarization, NSCLC cells were treated with CM collected from KMT2D-overexpressed THP-1 cells. The gene discussed is KMT2D; the disease is non-small cell lung carcinoma.